Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly’s Trulicity (dulaglutide) significantly improves A1C (average blood sugar concentration over two to three months) when added to ongoing…
Swedish Orphan Biovitrum AB has welcomed its new Chief Financial Officer who will join Sobi in late spring. Henrik Stenqvist…
Sanofi’s waiting period to complete the purchase of Bioverativ has came to an end, and will thus expand its hemophilia and other…
Gilead Sciences will begin a search for new Commercial Operation Executive Vice President in the coming weeks’s, as its current…
Allergan and Medicines360, a global nonprofit women’s health pharmaceutical company dedicated to expanding access to quality medicines, have announced that…
World’s largest HIV/AIDS drug-maker Mylan has received tentative approval for combination HIV treatment DTG/FTC/TAF under FDA’s PEPFAR program, the company…
Novo Nordisk has completed the first phase 3a trial, PIONEER 1, with oral semaglutide, for treating type 2 diabetes in…
Novartis has announced the publication of the CLAIM study in the Lancet Respiratory Medicine, which demonstrated that treatment once-daily Ultibro…
Vertex Pharmaceuticals wants to submit a New Drug Application in the USA, so it will soon give the final test…
BASF Corporation is introducing Hepaxa, a product that can help tens of millions of patients manage Non-Alcoholic Fatty Liver Disease…